CENERX BIOPHARMA INC

Profile

Company Names

CENERX BIOPHARMA INC

Addresses

270 CORNERSTONE DR, SUITE 103, CARY, NC 27519

Phone Numbers

919-523-0489

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$19,653,675.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2011-11-21 
$5,153,674.00 
$5,153,674.00 
$0.00 
Debt 
3
2010-08-05 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
2
2010-01-11 
$3,500,000.00 
$3,500,000.00 
$0.00 
Debt 
1
2009-06-10 
$4,000,001.00 
$4,000,001.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BARIC 
EXECUTIVE OFFICER, DIRECTOR
CENERX BIOPHARMA INC
MARK 
J 
BARIC 
EXECUTIVE OFFICER, DIRECTOR
CENERX BIOPHARMA INC
BARRY 
 
BRAND 
EXECUTIVE OFFICER, DIRECTOR
CENERX BIOPHARMA INC
STEVE 
 
ELMS 
DIRECTOR
CENERX BIOPHARMA INC   |  TRIA BEAUTY, INC.   |  NEXTWAVE PHARMACEUTICALS INC   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  AJAX HEALTH II LLC
STEVEN 
 
ELMS 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  CENERX BIOPHARMA INC   |  PERNIX THERAPEUTICS HOLDINGS, INC.   |  LOXO ONCOLOGY, INC.   |  14NER ONCOLOGY, INC.   |  ELEVATION ONCOLOGY, INC.   |  TREELINE BIOSCIENCES, INC.   |  MARKER THERAPEUTICS, INC.
TING 
PAU 
OEI 
DIRECTOR
CENERX BIOPHARMA INC   |  ELEME MEDICAL INC   |  INTRAPACE INC   |  ISCIENCE INTERVENTIONAL CORP   |  WELLTRACKONE CORP
ARTHUR 
 
PAPPAS 
DIRECTOR
CENERX BIOPHARMA INC   |  LEAD THERAPEUTICS, INC.   |  TYRX PHARMA INC   |  AFFERENT PHARMACEUTICALS, INC.   |  TYRX, INC.   |  BRAINCELLS INC   |  ASIA INNOVATION VENTURES, LP
ANTHONY 
 
SUN 
DIRECTOR
CENERX BIOPHARMA INC   |  NEOCONIX INC   |  BRIDGE PHARMACEUTICALS, INC.   |  LAVANTE INC   |  CANESTA INC   |  VERSARTIS, INC.   |  PACKET PHOTONICS, INC.   |  IMMUSOFT CORP   |  EYENOVIA, INC.   |  ALLOY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-06-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-21 
2011-11-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-21 
2011-01-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-05 
2010-12-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-05 
2010-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-08-05 
2010-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-01-11 
2009-06-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#